These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20571801)

  • 21. Comparison of contrast-enhanced ultrasound targeted biopsy versus standard systematic biopsy for clinically significant prostate cancer detection: results of a prospective cohort study with 1024 patients.
    Yunkai Z; Yaqing C; Jun J; Tingyue Q; Weiyong L; Yuehong Q; Wenbin G; Lifeng W; Jun Q
    World J Urol; 2019 May; 37(5):805-811. PubMed ID: 30187133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal combinations for detection of prostate cancer: systematic sextant and laterally directed biopsies versus systematic sextant and color Doppler-targeted biopsies.
    Kravchick S; Cytron S; Peled R; London D; Sibi Y; Ben-Dor D
    Urology; 2004 Feb; 63(2):301-5. PubMed ID: 14972476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrast-enhanced ultrasonography with contrast-tuned imaging technology for the detection of prostate cancer: comparison with conventional ultrasonography.
    Xie SW; Li HL; Du J; Xia JG; Guo YF; Xin M; Li FH
    BJU Int; 2012 Jun; 109(11):1620-6. PubMed ID: 21939490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can Sonovue targeted biopsy replace extended or saturation biopsy in prostate cancer diagnosis? Our experience at primary and repeat biopsy.
    Pepe P; Candiano G; Pennisi M; Aragona F
    Arch Ital Urol Androl; 2010 Sep; 82(3):155-9. PubMed ID: 21121433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimizing ultrasound-guided biopsy of musculoskeletal masses by application of an ultrasound contrast agent.
    Loizides A; Widmann G; Freuis T; Peer S; Gruber H
    Ultraschall Med; 2011 Jun; 32(3):307-10. PubMed ID: 20938892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contrast-enhanced colour Doppler-targeted prostate biopsy: correlation of a subjective blood-flow rating scale with the histopathological outcome of the biopsy.
    Mitterberger M; Aigner F; Pinggera GM; Steiner E; Rehder P; Ulmer H; Halpern EJ; Horninger W; Frauscher F
    BJU Int; 2010 Nov; 106(9):1315-8; discussion 1318. PubMed ID: 20346032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound-fusion biopsy for the diagnosis of prostate cancer.
    Borkowetz A; Platzek I; Toma M; Laniado M; Baretton G; Froehner M; Koch R; Wirth M; Zastrow S
    BJU Int; 2015 Dec; 116(6):873-9. PubMed ID: 25523210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of prostate cancer with a microbubble ultrasound contrast agent.
    Frauscher F; Klauser A; Halpern EJ; Horninger W; Bartsch G
    Lancet; 2001 Jun; 357(9271):1849-50. PubMed ID: 11410195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of perflubutane microbubble-enhanced ultrasound in imaging and detection of prostate cancer: phase II multicenter clinical trial.
    Uemura H; Sano F; Nomiya A; Yamamoto T; Nakamura M; Miyoshi Y; Miki K; Noguchi K; Egawa S; Homma Y; Kubota Y
    World J Urol; 2013 Oct; 31(5):1123-8. PubMed ID: 22311543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of serum prostate-specific antigen (PSA) level, prostate volume, and PSA density on prostate cancer detection with contrast-enhanced sonography using contrast-tuned imaging technology.
    Xie SW; Li HL; Du J; Xia JG; Guo YF; Xin M; Li FH
    J Ultrasound Med; 2013 May; 32(5):741-8. PubMed ID: 23620314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy--prospective multicenter study.
    Puech P; Rouvière O; Renard-Penna R; Villers A; Devos P; Colombel M; Bitker MO; Leroy X; Mège-Lechevallier F; Comperat E; Ouzzane A; Lemaitre L
    Radiology; 2013 Aug; 268(2):461-9. PubMed ID: 23579051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Echo-guided transrectal biopsy. An analysis of the results in a series of 1900 patients].
    Mayayo Dehesa T; Rodríguez-Patrón R; Zuccarino AL; Arias Funez F; Carrera Puerta C; García González R
    Arch Esp Urol; 1999 Jun; 52(5):453-63. PubMed ID: 10427883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contrast-enhanced harmonic ultrasonography for the assessment of prostate cancer aggressiveness: a preliminary study.
    Zhu Y; Chen Y; Jiang J; Wang R; Zhou Y; Zhang H
    Korean J Radiol; 2010; 11(1):75-83. PubMed ID: 20046498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrasound of prostate cancer: recent advances.
    Pallwein L; Mitterberger M; Pelzer A; Bartsch G; Strasser H; Pinggera GM; Aigner F; Gradl J; Zur Nedden D; Frauscher F
    Eur Radiol; 2008 Apr; 18(4):707-15. PubMed ID: 17938936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transrectal broadband-Doppler sonography with intravenous contrast medium administration for prostate imaging and biopsy in men with an elevated PSA value and previous negative biopsies.
    Taymoorian K; Thomas A; Slowinski T; Khiabanchian M; Stephan C; Lein M; Deger S; Lenk S; Loening SA; Fischer T
    Anticancer Res; 2007; 27(6C):4315-20. PubMed ID: 18214038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive Parameters Identifying Men Eligible for a Sole MRI/Ultrasound Fusion-Guided Targeted Biopsy without an Additional Systematic Biopsy.
    Günzel K; Haas M; Maxeiner A; Stephan C; Buckendahl J; Asbach P; Miller K; Kempkensteffen C; Cash H
    Urol Int; 2017; 98(1):15-21. PubMed ID: 27618633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Saturation biopsy technique increase the capacity to diagnose adenocarcinoma of prostate in patients with PSA < 10 ng/ml, after a first negative biopsy.
    Giulianelli R; Brunori S; Gentile BC; Vincenti G; Nardoni S; Pisanti F; Shestani T; Mavilla L; Albanesi L; Attisani F; Mirabile G; Schettini M
    Arch Ital Urol Androl; 2011 Sep; 83(3):154-9. PubMed ID: 22184840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Additive Value of Transrectal Systematic Ventral Biopsies in Combination with Magnet Resonance Imaging/Ultrasound Fusion-Guided Biopsy in Patients with 3 or More Negative Prostate Biopsies.
    Maxeiner A; Nest AM; Stephan C; Cash H; Baur ADJ; Fischer T; Kilic E; Piper SK; Nowak CP; Busch J; Miller K; Mang J
    Urol Int; 2020; 104(3-4):205-213. PubMed ID: 31801153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrast enhanced color Doppler endorectal sonography of prostate: efficiency for detecting peripheral zone tumors and role for biopsy procedure.
    Roy C; Buy X; Lang H; Saussine C; Jacqmin D
    J Urol; 2003 Jul; 170(1):69-72. PubMed ID: 12796647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of transrectal ultrasound probe on prostate cancer detection in transrectal ultrasound-guided sextant biopsy of prostate.
    Paul R; Korzinek C; Necknig U; Niesel T; Alschibaja M; Leyh H; Hartung R
    Urology; 2004 Sep; 64(3):532-6. PubMed ID: 15351585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.